Mamedica, a London, UK-based provider of cannabis-based prescription medicines, raised £4.5M in funding. Launched in 2022 by CEO and founder Jon Robson, Mamedica is a digital healthcare platform providing UK patients with access to cannabis-based prescription medicines across pain, psychiatry, neurology, palliative care and cancer. It provides specialist treatment for chronic and neurological conditions including pain, anxiety, ADHD and depression. Its digital model enables remote consultations with specialist clinicians, with medication delivered nationwide by secure next-day courier. Since inception, the company has treated over 10,000 patients, with approximately 7,500 actively under care and around 10% month-on-month growth in initial consultations.